Annual CFF
$8.51 M
+$16.45 M+207.10%
31 December 2023
Summary:
Kala Pharmaceuticals annual cash flow from financing activities is currently $8.51 million, with the most recent change of +$16.45 million (+207.10%) on 31 December 2023. During the last 3 years, it has fallen by -$152.12 million (-94.70%). KALA annual CFF is now -94.70% below its all-time high of $160.63 million, reached on 31 December 2020.KALA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$180.00 K
-$15.15 M-101.20%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly cash flow from financing activities is currently -$180.00 thousand, with the most recent change of -$15.15 million (-101.20%) on 30 September 2024. Over the past year, it has dropped by -$220.00 thousand (-550.00%). KALA quarterly CFF is now -100.14% below its all-time high of $131.18 million, reached on 31 March 2020.KALA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$25.77 M
-$220.00 K-0.85%
30 September 2024
Summary:
Kala Pharmaceuticals TTM cash flow from financing activities is currently $25.77 million, with the most recent change of -$220.00 thousand (-0.85%) on 30 September 2024. Over the past year, it has dropped by -$11.99 million (-31.76%). KALA TTM CFF is now -83.96% below its all-time high of $160.63 million, reached on 31 December 2020.KALA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +207.1% | -550.0% | -31.8% |
| 3 y3 years | -94.7% | -114.6% | -59.2% |
| 5 y5 years | -93.2% | -106.8% | -79.5% |
KALA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.7% | +207.1% | -100.6% | +99.5% | -59.2% | +165.1% |
| 5 y | 5 years | -94.7% | +207.1% | -100.1% | +99.5% | -84.0% | +165.1% |
| alltime | all time | -94.7% | +207.1% | -100.1% | +99.5% | -84.0% | +165.1% |
Kala Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$180.00 K(-101.2%) | $25.77 M(-0.8%) |
| June 2024 | - | $14.97 M(+77.4%) | $25.98 M(+84.4%) |
| Mar 2024 | - | $8.44 M(+232.9%) | $14.09 M(+65.6%) |
| Dec 2023 | $8.51 M(-207.1%) | $2.54 M(+6237.5%) | $8.51 M(-77.5%) |
| Sept 2023 | - | $40.00 K(-98.7%) | $37.76 M(-1852.1%) |
| June 2023 | - | $3.07 M(+7.5%) | -$2.15 M(-58.9%) |
| Mar 2023 | - | $2.86 M(-91.0%) | -$5.24 M(-34.0%) |
| Dec 2022 | -$7.94 M(-118.7%) | $31.79 M(-179.7%) | -$7.94 M(-79.9%) |
| Sept 2022 | - | -$39.87 M(>+9900.0%) | -$39.57 M(-2679.4%) |
| June 2022 | - | -$10.00 K(-106.5%) | $1.53 M(-79.3%) |
| Mar 2022 | - | $154.00 K(-3.8%) | $7.39 M(-82.6%) |
| Dec 2021 | $42.55 M(-73.5%) | $160.00 K(-87.0%) | $42.55 M(-32.6%) |
| Sept 2021 | - | $1.23 M(-79.0%) | $63.12 M(+0.8%) |
| June 2021 | - | $5.85 M(-83.4%) | $62.63 M(-3.3%) |
| Mar 2021 | - | $35.31 M(+70.4%) | $64.76 M(-59.7%) |
| Dec 2020 | $160.63 M | $20.72 M(+2677.7%) | $160.63 M(+9.9%) |
| Sept 2020 | - | $746.00 K(-90.7%) | $146.20 M(-1.3%) |
| June 2020 | - | $7.98 M(-93.9%) | $148.12 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $131.18 M(+1983.9%) | $140.13 M(+1460.2%) |
| Dec 2019 | $8.98 M(-92.8%) | $6.29 M(+135.9%) | $8.98 M(-92.8%) |
| Sept 2019 | - | $2.67 M(<-9900.0%) | $125.60 M(+2.1%) |
| June 2019 | - | -$10.00 K(-134.5%) | $122.98 M(-0.1%) |
| Mar 2019 | - | $29.00 K(-100.0%) | $123.04 M(-0.9%) |
| Dec 2018 | $124.10 M(+19.7%) | $122.92 M(>+9900.0%) | $124.10 M(>+9900.0%) |
| Sept 2018 | - | $45.00 K(-18.2%) | $552.00 K(-99.5%) |
| June 2018 | - | $55.00 K(-94.9%) | $105.62 M(+0.8%) |
| Mar 2018 | - | $1.09 M(-271.0%) | $104.80 M(+1.1%) |
| Dec 2017 | $103.70 M(+54.3%) | -$637.00 K(-100.6%) | $103.70 M(-1.5%) |
| Sept 2017 | - | $105.12 M(<-9900.0%) | $105.31 M(<-9900.0%) |
| June 2017 | - | -$765.00 K(+3926.3%) | -$808.00 K(-101.2%) |
| Mar 2017 | - | -$19.00 K(-101.9%) | $66.92 M(-0.4%) |
| Dec 2016 | $67.21 M(+541.4%) | $977.00 K(-197.6%) | $67.21 M(+1.5%) |
| Sept 2016 | - | -$1.00 M(-101.5%) | $66.24 M(-1.5%) |
| June 2016 | - | $66.96 M(>+9900.0%) | $67.24 M(>+9900.0%) |
| Mar 2016 | - | $276.00 K | $276.00 K |
| Dec 2015 | $10.48 M | - | - |
FAQ
- What is Kala Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual CFF year-on-year change?
- What is Kala Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly CFF year-on-year change?
- What is Kala Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM CFF year-on-year change?
What is Kala Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of KALA is $8.51 M
What is the all time high annual CFF for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual cash flow from financing activities is $160.63 M
What is Kala Pharmaceuticals annual CFF year-on-year change?
Over the past year, KALA annual cash flow from financing activities has changed by +$16.45 M (+207.10%)
What is Kala Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of KALA is -$180.00 K
What is the all time high quarterly CFF for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly cash flow from financing activities is $131.18 M
What is Kala Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, KALA quarterly cash flow from financing activities has changed by -$220.00 K (-550.00%)
What is Kala Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of KALA is $25.77 M
What is the all time high TTM CFF for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM cash flow from financing activities is $160.63 M
What is Kala Pharmaceuticals TTM CFF year-on-year change?
Over the past year, KALA TTM cash flow from financing activities has changed by -$11.99 M (-31.76%)